Answers are grounded in this paper and cite their sources.
Serum ferritin levels increase in severe COVID-19 patients. However, few data correlating the sensitivity and specificity of ferritin levels and mortality prediction in COVID-19 exist. The current study aims to investigate the sensitivity and specificity of ferritin for the prediction of mortality risks relative to COVID-19. Retrospectively, critically ill COVID-19 patients admitted to the general intensive care unit (ICU) of Ankara Bilkent City Hospital, Türkiye, were examined. The median baseline ferritin level in the survivor group was 184.7 µg/L (90.1–430.7), while it was 297.0 µg/L (150.3–851.3) in the deceased group (p = 0.001). The median maximum ferritin in the survivor group was 486.6 µg/L (187.9–1020.0), while it was 1456.7 µg/L (578.5–4388.1) in the deceased group (p < 0.001). In the receiver operating characteristic (ROC) curve analysis, the cut-off baseline ferritin value was 201.5 µg/L for the prediction of mortality (area under the curve [AUC] = 0.615, p < 0.001, 95% Confidence interval [CI]: 0.557–0.671). Baseline ferritin levels were associated with increased in-hospital mortality (p < 0.001, odds ratio: 2.347, 95% CI: 1.5–3.7). Baseline ferritin exhibited 66% sensitivity and 54.2% specificity in predicting mortality. The maximum ferritin cut-off value was 878.6 µg/L (AUC = 0.754, p < 0.001, 95% CI: 0.701–0.802), exhibiting 68% sensitivity and 73.2% specificity for mortality prediction. Ferritin has a moderately effective prediction potential for mortality in COVID-19 patients admitted to the ICU.
No takes yet. Share an insight, caveat, or question.
Soykan et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: